Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02847481 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
A Phase 1 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT02847481 is a Phase 1 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 80 participants.
The verdict
NCT02847481, a Phase 1 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a randomized pilot study to characterize engraftment of a donor's microflora onto patients with Irritable Bowel Syndrome with diarrhea following fecal microbiota transplantation.
Interventions
- PROCEDURE fecal microbiota transplantation
- DRUG placebo fecal microbiota transplantation
- PROCEDURE FMT with antibiotic pre-treatment (v1)
- PROCEDURE FMT with antibiotic pre-treatment (v2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-08-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02847481
The ClinicalTrials.gov registry entry for NCT02847481 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which fecal microbiota transplantation is the first listed.
NCT02847481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02847481 about?
NCT02847481 is a clinical study titled "A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS". This is a randomized pilot study to characterize engraftment of a donor's microflora onto patients with Irritable Bowel Syndrome with diarrhea following fecal microbiota transplantation.
What is the current status of trial NCT02847481?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2016-05. Estimated completion is 2018-08-05.
What interventions are being tested in trial NCT02847481?
The interventions under investigation include: fecal microbiota transplantation (PROCEDURE), placebo fecal microbiota transplantation (DRUG), FMT with antibiotic pre-treatment (v1) (PROCEDURE), FMT with antibiotic pre-treatment (v2) (PROCEDURE).
Who is sponsoring clinical trial NCT02847481?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.